Mingozzi Federico 4
4 · Spark Therapeutics, Inc. · Filed Jun 27, 2019
Insider Transaction Report
Form 4
Mingozzi Federico
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-26+8,375→ 15,390 total - Tax Payment
Common Stock
2019-06-26$102.31/sh−2,775$283,910→ 12,615 total - Exercise/Conversion
Restricted Stock Units
2019-06-26−8,375→ 16,750 total→ Common Stock (8,375 underlying)
Footnotes (3)
- [F1]Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics Inc. common stock.
- [F3]On September 29, 2017, the reporting person was granted 33,500 restricted stock units to vest in four equal installments. The second installment vested June 26, 2019, with the remaining two installments vesting annually thereafter. Vested shares will be delivered to the reporting person annually on the vesting date.